The title of this year’s symposium is “Menopause and Optimizing Midlife Health of Women.” The symposium will discuss the menopausal transition, the accumulation of morbidity after menopause, menopause in special populations, the influence of social determinants of health on the experience of menopause, the use of menopausal hormonal therapy, and interventions to promote healthy aging.
https://orwh.od.nih.gov/about/newsroom/events/7th-annual-vivian-w-pinn-symposium
The Vivian W. Pinn Symposium honors the first full-time director of National Institutes of Health (NIH) Office of Research on Women’s Health (ORWH), Dr. Vivian Pinn, and is held every year during National Women’s Health Week. This event serves as a critical forum for experts across sectors to communicate and collaborate for the advancement of women’s health.
Providing the keynote address, “Menopausal Hormone Therapy: 30 Years of Lessons from the Women’s Health Initiative,” is JoAnn Manson, M.D., M.P.H., Dr.P.H., MACP, Professor of Medicine and the Michael and Lee Bell Professor of Women’s Health, Harvard Medical School, Chief of Preventive Medicine, Brigham and Women’s Hospital, Boston. A patient advocacy panel will discuss the patient perspective of menopause.
The objectives of the symposium are to:
- Familiarize attendees with the state of the science related to our understanding of risk factors and mechanisms that lead to reproductive aging.
- Understand women’s unique morbidity and multimorbidity burden to identify points of intervention.
- Identify the needs of populations at risk for iatrogenic menopause (e.g., patients with germline inherited cancer risk) and early or complex menopausal symptoms (e.g., patients living with HIV, chronic conditions, and cancer).
- Identify priorities to address the influence of environmental, social, and other exposures as they relate to menopausal transition and symptoms in diverse populations of women.
- Understand current recommendations on menopausal hormone therapy prescribing, including doses, formulations, and durations of use.
